Cardiff Oncology, Inc.Cardiff Oncology, Inc.Cardiff Oncology, Inc.

Cardiff Oncology, Inc.

No trades
No trades

Fundamentals and stats

EPS and revenue snapshot

In the last quarter, the company reported −0.14 USD per share, beating the −0.12 USD estimate by −17.02%. Revenue for the same period reached ‪104.00 K‬ USD, despite the estimate of ‪62.78 K‬ USD. For the next quarter, analysts expect −0.14 USD in earnings per share and ‪81.43 K‬ USD in revenue.

Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise